{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:55:35Z","timestamp":1786136135824,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tem.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:22:10Z","timestamp":1786134130000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reappraisal of GLP-1 receptor agonists in older adults"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6770-3569","authenticated-orcid":false,"given":"Giuseppe","family":"Maltese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-1352","authenticated-orcid":false,"given":"Theocharis","family":"Koufakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2763-1326","authenticated-orcid":false,"given":"Djordje S.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2026.07.009_bb0005","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/jpm12111911","article-title":"Multimorbidity, frailty and diabetes in older people\u2014identifying interrelationships and outcomes","volume":"12","author":"Sinclair","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.tem.2026.07.009_bb0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ndt\/gfaf193","article-title":"The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis","volume":"41","author":"Sasaki","year":"2026","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2026.07.009_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108036","article-title":"Psychotropic effects of GLP-1R agonists","volume":"222","author":"Bucciarelli","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tem.2026.07.009_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview","volume":"20","author":"Prado","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2026.07.009_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4070\/kcj.2024.0089","article-title":"Frailty, sarcopenia, cachexia, and malnutrition in heart failure","volume":"54","author":"Maeda","year":"2024","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.tem.2026.07.009_bb0030","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/nu15071780","article-title":"The obesity paradox and mortality in older adults: a systematic review","volume":"15","author":"Drame","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2026.07.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101889","article-title":"Effect of frailty on cardiovascular clinical trials: a systematic review and meta-analysis","volume":"4","author":"Jiang","year":"2025","journal-title":"JACC Adv."},{"key":"10.1016\/j.tem.2026.07.009_bb0040","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1111\/dom.70666","article-title":"Lean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta-analysis of randomised controlled trials","volume":"28","author":"Eisa","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2026.07.009_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70063","article-title":"Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: a systematic review and meta-analysis","volume":"17","author":"Yang","year":"2025","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tem.2026.07.009_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjms.2022.08.016","article-title":"The complex pathophysiology of cardiac cachexia: a review of current pathophysiology and implications for clinical practice","volume":"365","author":"Thanapholsart","year":"2023","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tem.2026.07.009_bb0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00592-025-02611-2","article-title":"Muscle loss and GLP-1R agonists use","volume":"63","author":"Rossi","year":"2026","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.tem.2026.07.009_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae011","article-title":"Summary of best evidence for prevention and management of frailty","volume":"53","author":"Guo","year":"2024","journal-title":"Age Ageing"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:22:11Z","timestamp":1786134131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276026001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":12,"alternative-id":["S1043276026001803"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2026.07.009","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reappraisal of GLP-1 receptor agonists in older adults","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}